Ruediger Weseloh
Director/Board Member bij NYRADA INC.
Profiel
Rüdiger Weseloh is on the board of Nyrada, Inc. and Senior Director-Business Development at Merck KGaA, Executive Director-Business Development at EMD Serono, Inc. and Senior Director-Global Business Development at Merck Healthcare KGaA.
In his past career Rüdiger Weseloh held the position of Equity Analyst at Gontard & Metallbank AG, Senior Director at Merck Serono GmbH and Analyst at Oppenheim Research GmbH.
Dr. Weseloh received a graduate degree from the University of Bayreuth and a doctorate from Center For Molecular Neurobiology Hamburg.
Actieve functies van Ruediger Weseloh
Bedrijven | Functie | Begin |
---|---|---|
NYRADA INC. | Director/Board Member | 01-06-2019 |
MERCK KGAA | Corporate Officer/Principal | 01-01-2006 |
Merck Healthcare KGaA | Corporate Officer/Principal | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Eerdere bekende functies van Ruediger Weseloh
Bedrijven | Functie | Einde |
---|---|---|
Oppenheim Research GmbH | Analyst-Equity | 03-07-2006 |
GONTARD & METALLBANK AG | Corporate Officer/Principal | - |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Corporate Officer/Principal | - |
BIOXXMED AG | Director/Board Member | - |
Opleiding van Ruediger Weseloh
University of Bayreuth | Graduate Degree |
Center For Molecular Neurobiology Hamburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MERCK KGAA | Health Technology |
BIOXXMED AG | Health Technology |
NYRADA INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Gontard & Metallbank AG
Gontard & Metallbank AG Major BanksFinance Gontard & Metallbank AG provides banking and financial services. The company was founded by Wilhelm Merton in April 1999 and is headquartered in Frankfurt, Germany. | Finance |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Oppenheim Research GmbH | Finance |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck Serono GmbH is a German pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Darmstadt, Germany. The CEOs of the company are Matthias Pfannkuche, Angelika Heinl, Sören Hermansson. | Health Technology |
Merck Healthcare KGaA |